Editorial on the article entitled “brigatinib efficacy and safety in patients with anaplastic lymphoma kinase ( ALK )-positive nonsmall cell lung cancer in a phase I/II trial”

[摘要]

[发布日期] [发布机构]

[效力级别] [学科分类] 呼吸医学

[关键词] [时效性]

浏览次数：2

统一登录查看全文激活码登录查看全文